REFERENCES
- Brown MS. Goldstein JL. . Receptor-mediated control of cholesterol metabolism. Science 1976; 191: 150–4.
- Corsini A, Raiteri M, Soma MR, Fumaglli R, Paoletti R. Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes. Pharmacol Res 1991; 23: 173–80.
- Hidaka Y, Eda T, Yonemoto M, Kamei T. Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733). Athero-sclerosis 1992; 95: 87–94.
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–9.
- Sahni R, Maniet AR, Voci G, Banka VS. Prevention of restenosis by lovastatin after suc-cessful coronary angioplasty. Am Heart J 1990; 121: 1600–8.
- Brown MS, Faust JR, Goldstein JL, Kaneko I, Endo A. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibro-blasts induced with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem 1978; 253: 1121–8.
- Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–3.
- Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoproteins I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 1979; 260: 212–21.
- Glodstein JL, Basu SK, Brown MS. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 1983; 98: 241–61.
- Manderson JA, Mosse PRL, Safstrom JA, Young SB, Campbell GR. Balloon catheter injury to rabbit carotid artery. I. Changes in smooth muscle phenotype. Arteriosclerosis 1989; 9: 289–98.
- Shinomiya M, Shirai K, Saito Y, Yoshida S. Inhibition of intimal thickening of the carotid artery of rabbits and of outgrowth of explants of aorta by probucol. Atherosclerosis 1992; 97: 143–8.
- Fischer-Dzoga K, Jones RM, Vesselinovitch D, Wissler RW. Ultrastructural and immunohisto-chemical studies of primary cultures of aortic medial cells. Exp Mol Pathol 1976; 18: 162— 76.
- Koyama N, Morisaki N, Saito Y, Yoshida S. Regulatory effects of platelet-derived growth factor—AA homodimer on migration of vascular smooth muscle cells. J Biol Chem 1992; 267: 22806 — 12.
- Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 1992; 33: 1569–82.
- Koga T, Shimada Y, Kuroda M, Tsujita Y, Hasegawa K, Yamazaki M. Tissue-selective inhi-bition of cholesterol synthesis in vivo by pra-vastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim Biophys Acta 1990; 1045: 115–20.
- Soma MR, Donetti E, Parolini C, Mazzini G, Ferrari C, Fumaglli R, Paoletti R. HMG-CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rab-bits. Arterioscler Thromb 1993; 13: 571–8.
- Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425–30.
- Takai Y, Kaibuchi K, Kikuchi A, Kawata M. Small GTP-binding proteins. Int Rev Cytol 1992; 133: 187–230.
- Casey PJ, Solski PA, Der CJ, Buss JE. p21 ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 1989; 86: 8323–7.
- Miura Y, Kikuchi A, Musha T, Kuroda S, Yaku H, Sasaki T, Takai Y. Regulation of morphology by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in swiss 3T3 cells. J Biol Chem 1993; 268: 510–15.